• India bans pain killer 36 years after the US did so biospectrumasia
    November 16, 2018
    Indian health ministry bans sale of popular drugs – pain killer analgin, anti-diabetic drug pioglitazone and anti-depressant Deanxit
  • Admedus launches ADAPT technology in India October 11, 2018
    Physicians in India can now access the transformative power and significant patient benefits of ADAPT® engineered tissue and Admedus’ flagship product CardioCel® which is a bio-scaffold for the management of congenital and adult structural heart abnormali
  • Sun Pharma announces Australian TGA approval of ILUMYA biospectrumasia
    September 29, 2018
    ILUMYA is one of the key specialty products of Sun Pharma and it was approved by US FDA in March 2018 while the European Commission approved it in September 2018
  • Dr R Ananthanarayanan appointed as Cipla’s global COO financialexpress
    August 16, 2018
    He will oversee R&D, manufacturing, supply chain, the API business and the key geographies of North America, Europe and Emerging Markets
  • India loses its vaccine export sheen biospectrumasia
    August 15, 2018
    Vaccine exports from the country plunged by eight per cent during 2016-17 and nearly four per cent in the previous fiscal year.
  • India for formal recognition of traditional medicines in Singapore financialexpress
    June 29, 2018
    India is working towards formal recognition of traditional Indian medicines and practices in Singapore where there is a huge market
  • AstraZeneca receives DCG(I) nod for Durvalumab in India financialexpress
    June 29, 2018
    AstraZeneca Pharma India Limited (AZPIL) has received Import & Market permission for Durvalumab (ImfinziTM) in India by the Drug Controller General India, DCG(I). The receipt of this permission paves way for the launch of durvalumab (ImfinziTM) in India,
  • Is India jumping the gun on e-cigarettes? biospectrumasia
    June 25, 2018
    E-cigarettes do contain nicotine which, though it creates dependence, does not pose a major health risk, the US FDA has said while participating in the public debate on the effect of vaping on health.
  • Serum Institute of India and Intravacc to develop Bioneedles financialexpress
    June 01, 2018
    (L-R) Bruno Bruins, Dutch Minister for Medical Care and Sports,Mark Rutte, Prime Minister of the Netherlands,Thijs Veerman, CEO, Intravacc,Dr Suresh Jadhav
  • India, Sweden and The Netherlands form HIV/AIDS research partnership pharmafile
    May 25, 2018
    A first-of-its-kind collaboration has been announced by the governments of India, Sweden and The Netherlands with the goal of advancing research in the treatment of HIV and AIDS by leveraging the “complementary research strengths and diverse expertise” of
PharmaSources Customer Service